CADTH Reimbursement Review - Lutetium ( 177 - Lu) Vipivotide Tetraxetan (Pluvicto)

Canadian Agency for Drugs and Technologies in Health

Share artifact

Or copy link:

Register Login

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

Check your affiliation Start a trial

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Add to list

You have no lists yet

Manage lists

Citation

Health, C., 2023. CADTH Reimbursement Review - Lutetium ( 177 - Lu) Vipivotide Tetraxetan (Pluvicto), Canadian Agency for Drugs and Technologies in Health. Canada. Retrieved from https://canadacommons.ca/artifacts/4781441/cadth-reimbursement-review/5617737/ on 01 May 2024. CID: 20.500.12592/btt61g.

Download citation (RIS)

Full-page Screenshot

Screenshot of https://coherent-commons.s3.amazonaws.com/artifacts/file/file/65d221e6-ade0-477d-9c8d-a98baf74adf2.pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA23B6R4NTCRHS5NZ3%2F20240501%2Fus-east-2%2Fs3%2Faws4_request&X-Amz-Date=20240501T194727Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=846a3630cd2f0e79e3d4d8fcdba0794f78d99b4c264b870f87150ef79c88fa3d

CADTH Reimbursement Review - Lutetium ( 177 - Lu) Vipivotide Tetraxetan (Pluvicto)

Authors

Tables

Share artifact

Add to list

Citation

Full-page Screenshot